Molecular Diagnostics tests in Dubai & UAE

Compare available Molecular Diagnostics tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

781

Listed price range

550.00–150,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Molecular Diagnostics test prices

Showing 106–120 of 781 matching tests.

Molecular Diagnostics diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-436 Buffalo DNA Test This test evaluates genetic markers associated with behavioral traits, emotional resilience, and predisposition to psychological conditions using SNP analysis and AI-driven polygen...	Peripheral Whole Blood (2 mL EDTA), Saliva (Oragene DNA collection kit), or Buccal Swab	10–12 business days from sample receipt	2,000.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Single-nucleotide polymorphisms (SNPs) associated with behavioral traits", "Genetic markers linked to emotional resilience", "Polygenic Risk Score (PRS) for psychological conditions"] Parameters [] Preparation ["No specific fasting required", "No medication or diet adjustments needed"] Indications ["Psychogenomic screening", "Assessment of genetic predisposition to behavioral traits", "Support for mental wellness surveillance"] Measurement technique Confirm with laboratory Codes LOINC: 81267-4 ICD-10: Z13.89, Z13.4, Z13.49 Clinical summary This test evaluates genetic markers associated with behavioral traits, emotional resilience, and predisposition to psychological conditions using SNP analysis and AI-driven polygenic risk scoring.
TEST-664 C-KIT Mutation Detection PCR Test This test detects mutations in the KIT gene, which are associated with specific cancers and can guide treatment decisions.	Peripheral Whole Blood (4 mL, EDTA Tube)	10–12 working days	1,000.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["KIT gene mutations"] Parameters [] Preparation [] Indications ["Diagnosis of GIST", "Diagnosis of systemic mastocytosis", "Diagnosis of certain leukemias", "Prognostic assessment", "Guidance for targeted therapy"] Measurement technique Confirm with laboratory Codes LOINC: 40578-2 ICD-10: D37.1, C96.2 Clinical summary This test detects mutations in the KIT gene, which are associated with specific cancers and can guide treatment decisions.
TEST-1717 C-KIT Mutation Screening (Exons 9, 11, 13, 17) for AML Test This test identifies specific mutations within exons 9, 11, 13, and 17 of the C-KIT gene in a peripheral blood sample.	Peripheral Blood	7–8 working days	1,000.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["C-KIT gene mutations", "Acquired variants in KIT exons 9, 11, 13, 17"] Parameters [] Preparation ["No special preparation is required for the blood draw.", "Inform your healthcare provider of all medications and supplements you are taking."] Indications ["Diagnosis of Acute Myeloid Leukaemia (AML)", "Guiding targeted therapy selection in AML"] Measurement technique Confirm with laboratory Codes LOINC: 94218-1 ICD-10: C92.00 Clinical summary This test identifies specific mutations within exons 9, 11, 13, and 17 of the C-KIT gene in a peripheral blood sample.
TEST-1708 C‑Myc Oncogene FISH Test This diagnostic test evaluates for MYC gene amplifications and rearrangements within tumour tissue.	Tumour tissue (biopsy)	7–8 business days	1,200.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["MYC gene amplification", "MYC gene rearrangement"] Parameters [] Preparation ["No fasting required", "Inform healthcare team about all medications, especially anticoagulants or antiplatelet drugs"] Indications ["Prognostic guidance for aggressive cancers", "Therapeutic guidance for aggressive cancers"] Measurement technique Confirm with laboratory Codes LOINC: 21759-7 ICD-10: Z13.79 Clinical summary This diagnostic test evaluates for MYC gene amplifications and rearrangements within tumour tissue.
TEST-3380 C4BPA Gene Recurrent Pregnancy Loss Genetic Test This test evaluates the C4BPA gene for pathogenic variants associated with recurrent pregnancy loss using next-generation sequencing.	Whole blood, extracted DNA, or one drop blood on FTA card	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["C4BPA gene variants", "Single-nucleotide variants", "Small insertions/deletions", "Copy-number alterations"] Parameters [{"name": "Analytical Sensitivity", "reference_range": "99.9%"}, {"name": "Analytical Specificity", "reference_range": "99.9%"}, {"name": "Diagnostic Sensitivity", "reference_range": "99.9%"}] Preparation [] Indications ["Recurrent pregnancy loss (two or more unexplained losses)", "Exploring genetic causes for reproductive planning", "Informing potential immunotherapy", "Guiding preimplantation genetic testing"] Measurement technique Confirm with laboratory Codes LOINC: 94222-9 ICD-10: O26.86, Z31.5 Clinical summary This test evaluates the C4BPA gene for pathogenic variants associated with recurrent pregnancy loss using next-generation sequencing.
TEST-4183 CALM2 Gene Long QT Syndrome Type 15 Genetic Test This test evaluates the CALM2 gene for pathogenic variants associated with Long QT syndrome type 15.	Peripheral Whole Blood or Buccal Swab (DNA FTA Card)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the CALM2 gene"] Parameters [] Preparation ["Continue all prescribed medications unless instructed otherwise by your physician", "Mandatory genetic counseling session required"] Indications ["Suspected Long QT syndrome type 15", "Family history of Long QT syndrome or sudden cardiac death"] Measurement technique Confirm with laboratory Codes LOINC: 81237-0 ICD-10: I45.81 Clinical summary This test evaluates the CALM2 gene for pathogenic variants associated with Long QT syndrome type 15.
TEST-5574 CALR Gene (Schizophrenia Susceptibility) Genetic Test This genetic test evaluates the CALR gene for mutations potentially linked to an increased risk of developing schizophrenia.	Peripheral blood, buccal swab, or dried blood spot	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CALR gene mutations", "Copy Number Variations (CNV) in CALR gene"] Parameters [] Preparation ["No fasting or special preparation is needed."] Indications ["Assessment of genetic predisposition to schizophrenia", "Risk stratification in individuals with family history"] Measurement technique Confirm with laboratory Codes LOINC: 94120-2 ICD-10: Z13.89 Clinical summary This genetic test evaluates the CALR gene for mutations potentially linked to an increased risk of developing schizophrenia.
TEST-509 CALR Mutation Detection Test This test identifies pathogenic variants in the calreticulin (CALR) gene, aiding in the diagnosis and classification of Philadelphia-negative myeloproliferative neoplasms (MPNs).	Peripheral Whole Blood (EDTA)	5 business days (sample Mon by 11 am → report Sat)	850.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CALR gene mutations", "Pathogenic variants in calreticulin"] Parameters [] Preparation ["No special preparation needed", "Ensure treating physician completes Genomics Clinical Information Requisition Form (Form 20)"] Indications ["Diagnosis of essential thrombocythemia", "Diagnosis of primary myelofibrosis", "Classification of Philadelphia-negative MPNs"] Measurement technique Confirm with laboratory Codes LOINC: 94474-0 ICD-10: D47.3, D47.1 Clinical summary This test identifies pathogenic variants in the calreticulin (CALR) gene, aiding in the diagnosis and classification of Philadelphia-negative myeloproliferative neoplasms (MPNs).
TEST-517 Cancer 50 Gene Panel (NGS) Test This test identifies mutations in 50 genes linked to cancer development and progression.	Peripheral Blood (EDTA) or FFPE Tumour Tissue Block	10 working days	4,600.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Single nucleotide variants", "Small insertions and deletions", "Copy number alterations", "Variant allele frequency"] Parameters [] Preparation ["No specific fasting required.", "Do not discontinue prescribed medications without consulting your physician."] Indications ["Individuals with a personal or family history of cancer seeking targeted therapy guidance.", "Oncology patients requiring molecular profiling for treatment decisions.", "Asymptomatic individuals with a strong familial cancer pattern.", "Hematologic malignancies", "Solid neoplasms"] Measurement technique Confirm with laboratory Codes LOINC: 91847-2 ICD-10: Z12.89, C80.1 Clinical summary This test identifies mutations in 50 genes linked to cancer development and progression.
TEST-521 Cancer Gene Any 3 Markers NGS Test This test identifies pathogenic variants in three selected genes associated with hereditary cancer syndromes using next-generation sequencing.	Whole Blood (EDTA, Lavender Top) or FFPE Tissue Block	10 working days	2,500.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants (SNVs, indels, CNVs) in three selected cancer susceptibility genes", "Analytical sensitivity for variant detection"] Parameters [] Preparation [] Indications ["Personal or family history suggestive of hereditary cancer syndrome", "Early-onset cancer diagnosis", "Multiple primary cancers", "Specific cancer types associated with hereditary syndromes (e.g., breast, ovarian, colorectal, prostate, pancreatic)"] Measurement technique Confirm with laboratory Codes LOINC: 92981-5 ICD-10: Z15.09 Clinical summary This test identifies pathogenic variants in three selected genes associated with hereditary cancer syndromes using next-generation sequencing.
TEST-531 Cancer Targeted Gene Panel (Colon/Colorectal) Test This test evaluates tumor tissue for specific genetic mutations (KRAS, NRAS, BRAF) and microsatellite instability (MSI) status relevant to colorectal cancer.	Formalin-Fixed Paraffin-Embedded (FFPE) tissue block or slides – Archival Tissue Specimen	10 working days from Tuesday sample receipt	2,700.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["KRAS mutations", "NRAS mutations", "BRAF mutations", "MSI status", "Fragment/STR Analysis"] Parameters [] Preparation ["Submit FFPE block with at least 10% tumor tissue", "Include mandatory NGS Requisition Form (Form 40)"] Indications ["Diagnosis of colorectal cancer", "Guiding targeted therapy selection", "Prognosis assessment"] Measurement technique Confirm with laboratory Codes LOINC: 92916-2 ICD-10: C18.9, C20 Clinical summary This test evaluates tumor tissue for specific genetic mutations (KRAS, NRAS, BRAF) and microsatellite instability (MSI) status relevant to colorectal cancer.
TEST-537 Cancer Targeted Gene Panel (Lung) Test This test evaluates lung cancer tissue for specific genetic mutations, fusions, and copy number changes relevant to targeted therapy.	Formalin-Fixed Paraffin-Embedded (FFPE) Tissue Block or Biopsy Slides – Archival Specimen	10 working days	3,500.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Actionable mutations", "Fusions", "Copy number changes", "EGFR", "ALK", "ROS1", "KRAS", "BRAF"] Parameters [] Preparation ["No fasting required", "Ensure the NGS Requisition Form (Form 40) is completed"] Indications ["Diagnosis of lung cancer", "Guiding targeted therapy", "Guiding immunotherapy decisions"] Measurement technique Confirm with laboratory Codes LOINC: 75504-0 ICD-10: C34.9 Clinical summary This test evaluates lung cancer tissue for specific genetic mutations, fusions, and copy number changes relevant to targeted therapy.
TEST-528 Cancer Targeted Gene Panel: Lung with PD‑L1 (DAKO) Test This test evaluates key genetic mutations, rearrangements, and PD-L1 expression in lung cancer tissue.	Archival FFPE Tissue Block or Biopsy Slides	10–14 business days from receipt of adequate specimen	4,500.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Driver mutations (>50 key genes)", "Gene rearrangements", "PD-L1 tumour proportion score (TPS)"] Parameters [] Preparation [] Indications ["Diagnosis of non-small cell lung cancer (NSCLC)", "Guiding targeted therapy selection", "Guiding immunotherapy selection"] Measurement technique Confirm with laboratory Codes LOINC: 96539-6 ICD-10: C34.9 Clinical summary This test evaluates key genetic mutations, rearrangements, and PD-L1 expression in lung cancer tissue.
TEST-356 Canola / Rapeseed GMO Testing Test This diagnostic test evaluates canola/rapeseed samples for the presence of genetically modified sequences using PCR.	Seed, Plant Tissue	4 Working Days	1,000.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Presence of GMO sequences in Canola/Rapeseed"] Parameters [] Preparation [] Indications ["Health-conscious individuals seeking non-GMO verification", "Regulatory compliance"] Measurement technique Confirm with laboratory Codes LOINC: 74897-7 ICD-10: Z13.8 Clinical summary This diagnostic test evaluates canola/rapeseed samples for the presence of genetically modified sequences using PCR.
TEST-4925 CARD11 Gene Immunodeficiency Type 11 Genetic Test This test identifies pathogenic variants in the CARD11 gene, confirming a diagnosis of Autosomal Dominant Immunodeficiency Type 11.	Peripheral Whole Blood	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the CARD11 gene", "Coverage of coding regions and canonical splice sites"] Parameters [] Preparation ["No fasting required", "Inform phlebotomist of anticoagulant or antiplatelet medications"] Indications ["Suspected Autosomal Dominant Immunodeficiency Type 11", "Family screening for CARD11 variants"] Measurement technique Confirm with laboratory Codes LOINC: 96601-4 ICD-10: D81.89 Clinical summary This test identifies pathogenic variants in the CARD11 gene, confirming a diagnosis of Autosomal Dominant Immunodeficiency Type 11.

Category overview

Molecular Diagnostics: overview

When complex health questions arise, evaluating your health at the cellular level provides the definitive clarity necessary for proactive care. At DNA Labs UAE, our Molecular Diagnostics services harness the power of advanced nucleic acid amplification and real-time PCR technologies to detect diseases with unparalleled sensitivity. From identifying viral loads to pinpointing genetic markers, our specialized molecular testing in the UAE gives your healthcare provider the precise data needed to customize your medical strategy. Trust in one of the leading diagnostic labs in Dubai and the UAE to process your samples with rigorous confidentiality and exceptionally fast, accurate turnaround times. Step forward with absolute confidence. View our molecular diagnostics profiles below, request a seamless home sample collection, or contact our specialized team to book your test.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.

Explore this area

Molecular Diagnostics tests in Dubai & UAE

Molecular Diagnostics test prices

Molecular Diagnostics: overview

Use the test details as a conversation starter

Related Molecular Diagnostics categories